MOZOBIL INJECTION 24mg/1.2 ml vial (Plerixafor)
Reliable shipping
Flexible returns
MOZOBIL INJECTION 24mg/1.2 ml vial (Plerixafor) is a critical medication used primarily in the field of oncology and hematology. It plays an essential role in mobilizing hematopoietic stem cells from the bone marrow into the bloodstream, making them accessible for collection and subsequent transplantation. This is particularly beneficial for patients undergoing stem cell transplant procedures.
One of the key highlights of MOZOBIL is its mechanism of action. Plerixafor works by inhibiting the interaction between the chemokine receptor CXCR4 and its ligand, stromal-derived factor-1 (SDF-1). This disruption facilitates the release of stem cells into the peripheral blood, enhancing the efficiency of stem cell collection.
MOZOBIL is typically administered via subcutaneous injection, allowing for easy and effective delivery. Patients are usually given this medication in conjunction with granulocyte-colony stimulating factor (G-CSF) to maximize stem cell mobilization. The combination enhances the yield of stem cells collected, which is crucial for successful transplant outcomes.
Safety and efficacy are paramount with any medication, and MOZOBIL has undergone rigorous clinical trials to establish its profile. Common side effects may include injection site reactions, diarrhea, and nausea, but these are generally manageable. It is important for healthcare providers to monitor patients closely during treatment.
In summary, MOZOBIL INJECTION 24mg/1.2 ml vial (Plerixafor) is a vital therapeutic agent for patients requiring stem cell mobilization. Its unique mechanism of action, combined with its effectiveness in improving stem cell collection, makes it a valuable tool in the treatment of various hematologic conditions.
- Plerixafor
- Water for injection
- Hydrochloric acid (for pH adjustment)
- Sodium hydroxide (for pH adjustment)
MOZOBIL INJECTION (Plerixafor) is a medication used to mobilize hematopoietic stem cells prior to collection for transplantation. Follow these instructions carefully to ensure safe and effective use of the product.
Before administration, ensure that you have reviewed the patient’s medical history and confirmed that Plerixafor is appropriate for their treatment plan.
Gather all necessary materials, including the MOZOBIL vial, a syringe, alcohol swabs, and gloves. Maintain a clean workspace to minimize contamination.
Inspect the vial for any discoloration or particulate matter. If the solution appears cloudy or has particles, do not use it and consult a pharmacist.
Wash your hands thoroughly and put on gloves to maintain sterility.
Using an alcohol swab, clean the rubber stopper of the MOZOBIL vial. Allow it to dry to ensure sterility.
Draw air into the syringe equal to the dose you will be administering (24 mg). Insert the needle into the vial and inject the air to create a vacuum, then draw the required amount of Plerixafor into the syringe.
Remove any air bubbles by gently tapping the syringe and pushing the plunger slightly until a drop of medication appears at the tip of the needle.
Select an appropriate injection site, usually the abdomen or thigh. Clean the area with an alcohol swab and allow it to dry.
Insert the needle at a 90-degree angle to the skin. If using a subcutaneous injection, you may use a 45-degree angle depending on the patient’s body fat.
Inject the medication slowly and steadily. After the injection, withdraw the needle quickly and apply gentle pressure to the site with a cotton ball or gauze.
Dispose of the needle and syringe in a sharps container. Remove your gloves and wash your hands thoroughly.
Monitor the patient for any adverse reactions after the injection, and ensure they understand the importance of reporting any unusual symptoms.
Always follow the specific guidelines provided by the prescribing physician and consult with a healthcare professional if you have any questions or concerns regarding the administration of MOZOBIL.